is retatrutide glp-1 or glp 3 Beyond GLP-1: Retatrutide's triple-agonist mechanism (GLP-1, GIP, glucagon) redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside prescribing GLP-3 RT – True Lab

The potential biological mechanisms underlying their influence on cancer risk are complex, involving metabolic regulation, direct antitumor effects, immune modulation, and epigenetic changes

Retatrutide affects multiple metabolic pathways related to appetite, digestion, blood sugar, and energy balance

Medications such as semaglutide (popular brand names such as Wegovy and Ozempic) are now widely recognized not only for promoting weight loss but also for providing significant metabolic benefits

Second, the source of the 300% claim is not clearly attributed to a published, peer-reviewed study on resM specifically

Published: June 2, 2026 | Last reviewed: June 2, 2026 Reviewed by: Dr